Interestingly, DLCs induced redifferentiation with enhanced NIS expression in several thyroid cancer cell lines irrespective of mutations such as BRAF, PTEN loss, or RET/PTC rearrangement. This evidence concerns the gene PTEN and thyroid gland carcinoma.